IMPW 2025 Day5: Potential of AI on Nuclear Medicine Imaging and Therapy

Potential of AI on Nuclear Medicine Imaging and Therapy

Friday, 9 May 2025 at 12 pm GMT; Duration 1 hour

Organizer: Chai Hong Yeong, IOMP MPWB Chair

Moderators: Ibrahim Duhaini and Francis Hasford

Speakers: Kuangyu Shi, Ph.D and Axel Rominger, M.D.

Abstract:

Recent advances in instrumentation and radiopharmaceutical therapy (RPT) present new opportunities for nuclear medicine. However, the increasing complexity and data volume of these advancements makes fully exploring their potential more challenging. Artificial intelligence (AI) offers a promising tool to address these challenges. AI can assist in optimizing signal processing and image reconstruction, enhancing imaging quality while reducing radiation exposure. It can also improve diagnosis and prognosis in nuclear medicine imaging, facilitating tasks such as differential and early diagnosis. Additionally, AI has the potential to support the development of treatment planning tools for RPT, including simplified dosimetry procedures and pre-therapy dose prediction. This talk will explore the role of AI in imaging optimization, diagnostic assistance, and treatment planning from several developments from Bern. We will also discuss the challenges of AI implementation in nuclear medicine and the transformative potential of knowledge-guided AI in theranostics.

Learning Objectives:

Understand the potential of AI in the optimization of nuclear medicine imaging.
Understand the potential of AI in personalized radiopharmaceutical therapy.
Understand the concept of knowledge-guidance for trustworthy AI.